First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial
2019 · Molecular Therapy · 59 citations
https://doi.org/10.1016/j.ymthe.2019.08.020
B
Bhuvana A. Setty
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
80
Papers
801
Citations
15
h-index
20
i10-index
Bhuvana A. Setty is an academic researcher from Nationwide Children's Hospital. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Neuroblastoma Research and Treatments & Cancer Genomics and Diagnostics. The author has an h-index of 15, co-authored 68 publications.
ORCID: 0000-0002-6054-817XPapers by this author
worksDiscovery of clinically relevant fusions in pediatric cancer
2021 · BMC Genomics · 31 citations
https://doi.org/10.1186/s12864-021-08094-z
Progress in sarcomas: Highlights from the 2023 annual meeting of the Connective Tissue Oncology Society
2024 · Molecular Therapy Oncology · 2 citations
https://doi.org/10.1016/j.omton.2024.200779
Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma
2024 · Pediatric Blood & Cancer · 2 citations
https://doi.org/10.1002/pbc.31477
Additional file 2 of Discovery of clinically relevant fusions in pediatric cancer
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.17126039
Additional file 3 of Discovery of clinically relevant fusions in pediatric cancer
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.17126042
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat